【肺栓塞患者随访中的临床器械管理和抗凝治疗:ANMCO肺血管疾病工作组推动的“FOLLOW-EP”调查结果】。

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Iolanda Enea, Maria Cristina Vedovati, Laura Scelsi, Andrea Garascia, Sergio Caravita, Claudio Picariello
{"title":"【肺栓塞患者随访中的临床器械管理和抗凝治疗:ANMCO肺血管疾病工作组推动的“FOLLOW-EP”调查结果】。","authors":"Iolanda Enea, Maria Cristina Vedovati, Laura Scelsi, Andrea Garascia, Sergio Caravita, Claudio Picariello","doi":"10.1714/4454.44488","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Follow-up management of patients with pulmonary embolism (PE) is crucial to reduce the risk of recurrence and the early identification of those who develop pulmonary hypertension. However, this pathway is poorly defined.</p><p><strong>Methods: </strong>The ANMCO Working Group on Pulmonary Vascular Diseases together with the ANMCO Study Center addressed a web-based set of 16 questions to ANMCO members to investigate their experience in PE follow-up settings and adherence to guidelines.</p><p><strong>Results: </strong>Out of 4488 submissions, 294 (6.5%) answered, of which 69% were cardiologists. An outpatient clinic for PE follow-up is not present in 43% of the centers, in 28% it is present in a structured form and in 27% only as an outpatient clinic for anticoagulant therapy (AC). The referring doctor is a cardiologist in 68% of cases. The first visit after PE is usually at 3 months (60%). The bleeding and recurrence risk profiles are assessed in 63% and 36% of cases, respectively. Thrombophilia screening guides AC discontinuation after idiopathic PE (47%), especially in women and young people (55%). Risk factors associated with the index event are decisive for AC extended duration in estrogen-progestin-induced PE (69%) as well as in incidental PE (80%). In the extended phase, direct oral anticoagulants (DOACs) at low dose are used in 45% in accordance with current literature, in 40% due to the risk of bleeding. In patients with active cancer, 47% continue DOACs at full dose indefinitely, 36% at reduced dose. In 93% of cases, exertional dyspnea in the follow-up leads to the request for additional tests: a ventilation-perfusion scan in 44%, a pulmonary computed tomography angiography in 34%.</p><p><strong>Conclusions: </strong>The data collected show wide heterogeneity in the follow-up management of PE. Dedicated clinics and local pathways are needed in caring for the patient after an episode of PE.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"26 3","pages":"195-204"},"PeriodicalIF":0.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: the results of the \\\"FOLLOW-EP\\\" survey promoted by the ANMCO Working Group on Pulmonary Vascular Diseases].\",\"authors\":\"Iolanda Enea, Maria Cristina Vedovati, Laura Scelsi, Andrea Garascia, Sergio Caravita, Claudio Picariello\",\"doi\":\"10.1714/4454.44488\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Follow-up management of patients with pulmonary embolism (PE) is crucial to reduce the risk of recurrence and the early identification of those who develop pulmonary hypertension. However, this pathway is poorly defined.</p><p><strong>Methods: </strong>The ANMCO Working Group on Pulmonary Vascular Diseases together with the ANMCO Study Center addressed a web-based set of 16 questions to ANMCO members to investigate their experience in PE follow-up settings and adherence to guidelines.</p><p><strong>Results: </strong>Out of 4488 submissions, 294 (6.5%) answered, of which 69% were cardiologists. An outpatient clinic for PE follow-up is not present in 43% of the centers, in 28% it is present in a structured form and in 27% only as an outpatient clinic for anticoagulant therapy (AC). The referring doctor is a cardiologist in 68% of cases. The first visit after PE is usually at 3 months (60%). The bleeding and recurrence risk profiles are assessed in 63% and 36% of cases, respectively. Thrombophilia screening guides AC discontinuation after idiopathic PE (47%), especially in women and young people (55%). Risk factors associated with the index event are decisive for AC extended duration in estrogen-progestin-induced PE (69%) as well as in incidental PE (80%). In the extended phase, direct oral anticoagulants (DOACs) at low dose are used in 45% in accordance with current literature, in 40% due to the risk of bleeding. In patients with active cancer, 47% continue DOACs at full dose indefinitely, 36% at reduced dose. In 93% of cases, exertional dyspnea in the follow-up leads to the request for additional tests: a ventilation-perfusion scan in 44%, a pulmonary computed tomography angiography in 34%.</p><p><strong>Conclusions: </strong>The data collected show wide heterogeneity in the follow-up management of PE. Dedicated clinics and local pathways are needed in caring for the patient after an episode of PE.</p>\",\"PeriodicalId\":12510,\"journal\":{\"name\":\"Giornale italiano di cardiologia\",\"volume\":\"26 3\",\"pages\":\"195-204\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di cardiologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1714/4454.44488\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1714/4454.44488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:肺栓塞(PE)患者的随访管理对于降低复发风险和早期识别肺动脉高压患者至关重要。然而,这一途径的定义并不明确:ANMCO肺血管疾病工作组与ANMCO研究中心一起向ANMCO成员提出了一套16个问题的网络问题,以调查他们在PE随访环境中的经验以及对指南的遵守情况:在 4488 份提交的问卷中,有 294 份(6.5%)做出了回答,其中 69% 是心脏病专家。43%的中心未设立 PE 随访门诊,28%的中心以结构化形式设立了 PE 随访门诊,27%的中心仅设立了抗凝治疗门诊(AC)。68%的转诊医生是心脏病专家。PE 后的首次就诊时间通常为 3 个月(60%)。分别有 63% 和 36% 的患者接受了出血和复发风险评估。特发性 PE(47%)后,血栓性疾病筛查可指导停用 AC,尤其是女性和年轻人(55%)。在雌激素-孕激素诱发的 PE(69%)和偶发性 PE(80%)中,与指数事件相关的风险因素是延长 AC 持续时间的决定性因素。在延长阶段,45%的患者根据现有文献使用小剂量直接口服抗凝剂(DOACs),40%的患者因出血风险而使用DOACs。在活动性癌症患者中,47%的患者继续无限期使用全剂量 DOACs,36%的患者使用减量 DOACs。在93%的病例中,随访期间出现的劳力性呼吸困难导致患者要求进行额外检查:44%的患者需要进行通气-灌注扫描,34%的患者需要进行肺部计算机断层扫描:收集到的数据显示,PE 的随访管理存在很大差异。结论:收集到的数据显示,在 PE 的随访管理方面存在很大的差异。在 PE 病发后,需要有专门的诊所和地方路径来护理病人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: the results of the "FOLLOW-EP" survey promoted by the ANMCO Working Group on Pulmonary Vascular Diseases].

Background: Follow-up management of patients with pulmonary embolism (PE) is crucial to reduce the risk of recurrence and the early identification of those who develop pulmonary hypertension. However, this pathway is poorly defined.

Methods: The ANMCO Working Group on Pulmonary Vascular Diseases together with the ANMCO Study Center addressed a web-based set of 16 questions to ANMCO members to investigate their experience in PE follow-up settings and adherence to guidelines.

Results: Out of 4488 submissions, 294 (6.5%) answered, of which 69% were cardiologists. An outpatient clinic for PE follow-up is not present in 43% of the centers, in 28% it is present in a structured form and in 27% only as an outpatient clinic for anticoagulant therapy (AC). The referring doctor is a cardiologist in 68% of cases. The first visit after PE is usually at 3 months (60%). The bleeding and recurrence risk profiles are assessed in 63% and 36% of cases, respectively. Thrombophilia screening guides AC discontinuation after idiopathic PE (47%), especially in women and young people (55%). Risk factors associated with the index event are decisive for AC extended duration in estrogen-progestin-induced PE (69%) as well as in incidental PE (80%). In the extended phase, direct oral anticoagulants (DOACs) at low dose are used in 45% in accordance with current literature, in 40% due to the risk of bleeding. In patients with active cancer, 47% continue DOACs at full dose indefinitely, 36% at reduced dose. In 93% of cases, exertional dyspnea in the follow-up leads to the request for additional tests: a ventilation-perfusion scan in 44%, a pulmonary computed tomography angiography in 34%.

Conclusions: The data collected show wide heterogeneity in the follow-up management of PE. Dedicated clinics and local pathways are needed in caring for the patient after an episode of PE.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Giornale italiano di cardiologia
Giornale italiano di cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信